| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,350,000 | 3,006,300 | 3,159,900 | 3,526,900 | | Cost of Revenue | (4,297,500) | 4,297,500 |
-
| 2,251,900 | | | Gross Profit | 7,647,500 | (1,291,200) | 3,159,900 | 1,275,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,050,200 | (1,688,200) | 2,910,100 | 678,600 | | Non Recurring | 31,700 | 9,600 |
-
| 147,500 | | Others | 147,400 | 145,200 | 142,300 | 150,700 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 418,200 | 242,200 | 107,500 | 298,200 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 16,600 | (32,900) | (9,600) | 7,600 | | Earnings Before Interest And Taxes | 464,600 | 209,300 | 97,900 | 305,800 | | Interest Expense | 135,400 | 133,900 | 133,200 | 138,800 | | Income Before Tax | 329,200 | 75,400 | (35,300) | 167,000 | | Income Tax Expense | 79,700 | 56,900 | 8,800 | 28,600 | | Minority Interest |
-
|
-
|
-
| 900 | | | | Net Income From Continuing Ops | 207,600 | 15,400 | (55,300) | 136,100 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 207,600 | 15,400 | (55,300) | 136,100 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $207,600 | $15,400 | ($55,300) | $136,100 |
|
1.23% Nasdaq 
Income Statement
